Group 1 - ZTE Corporation plans to invest 200 million RMB to subscribe to the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Guidance Fund, focusing on areas supported by national policies such as new generation information technology and biotechnology [1] - Huayi Jewelry's subsidiary has reported overdue loans totaling 200 million RMB due to tight liquidity, with a cumulative overdue principal of 254 million RMB [2] - Guangzhou Baiyunshan Pharmaceutical's subsidiary has received approval for the consistency evaluation of Alfacalcidol soft capsules, which are used to treat calcium metabolism disorders [3] Group 2 - Kunming Pharmaceutical Group reported a 21.72% decline in revenue to 6.577 billion RMB and a 46% drop in net profit to 350 million RMB for 2025 [4] - Jiantou Energy's application for a specific stock issuance has been approved by the Shenzhen Stock Exchange [5] - Jinchuan Titanium Industry's subsidiary has temporarily suspended its sulfuric acid production due to reduced demand [6] Group 3 - Kelun Pharmaceutical's subsidiary has received approval for a new indication for its antibody-drug conjugate, which is used to treat advanced hormone receptor-positive breast cancer [7] - Fawer Co., Ltd. has completed the relocation of its Chongqing Yuantai Shock Absorber Company and commenced production [8] - Jiuzhoutong's subsidiary has received acceptance for the listing application of Betahistine Hydrochloride tablets [9] Group 4 - Zhongguancun plans to build a traditional Chinese medicine and raw material drug production base in Jiamusi City, Heilongjiang Province [11] - China Wuyi announced that part of its land in Kenya has been requisitioned by the government, with compensation of approximately 6.25 million RMB [12] - Times Electric reported a 15.46% increase in revenue to 28.761 billion RMB and a 10.88% increase in net profit to 4.105 billion RMB for 2025 [13] Group 5 - Top Cloud Agriculture's shareholder has received regulatory measures from the Zhejiang Securities Regulatory Bureau for failing to timely disclose shareholding changes [14] - Xinwanda's subsidiary has reached a settlement in a lawsuit involving over 2.314 billion RMB, with an estimated impact of 500 to 800 million RMB on net profit for 2025 [15] - Dongrui Co., Ltd. reported a 25.19% increase in pig sales revenue in January, totaling 214 million RMB [16] Group 6 - Tianjin Tianshi reported a 3.08% decline in revenue to 8.236 billion RMB, while net profit increased by 15.68% to 1.105 billion RMB for 2025 [17] - Wantong Expressway plans to invest approximately 5.42 billion RMB in the renovation and expansion of the Lianhuo Expressway [18] - Qiaoyin Co., Ltd. has pre-qualified for a sanitation integration service project worth approximately 73.8 million RMB [20] Group 7 - Jindi Co., Ltd. plans to acquire 100% equity of Yuni Precision for 116 million RMB, focusing on precision stamping products [21] - Heng Rui Medicine's HRS-4642 injection has been included in the list of breakthrough therapeutic varieties [22] - Tongde Chemical has had some assets frozen due to a financing lease dispute [23] Group 8 - Zhongli Co., Ltd. is establishing an industrial fund with a total commitment of approximately 408.76 million RMB, focusing on new materials and artificial intelligence [24] - Tianbang Food reported a 9.93% increase in pig sales revenue in January, totaling 674 million RMB [25] - New Hope reported a 10.03% decrease in pig sales revenue in January, totaling 1.628 billion RMB [26] Group 9 - Tainkang's subsidiary has received a drug registration certificate for Minoxidil topical solution [27] - Lihua Co., Ltd. reported a 9.8% increase in chicken sales revenue in January, totaling 1.289 billion RMB [28] - Guojitong General reported a 45.71% increase in net profit to 58.52 million RMB for 2025 [29] Group 10 - Zhixin Co., Ltd. plans to invest up to 1.1 billion RMB in an automotive stamping and welding parts project [30] - Chuangyuan Technology's subsidiary has pre-qualified for a National Grid project worth approximately 94.77 million RMB [31] - Lisheng Pharmaceutical's adenine phosphate raw material has passed the listing application [32] Group 11 - Tongguang Cable's subsidiary has pre-qualified for a National Grid project worth approximately 108 million RMB [33] - Zhenghong Technology reported a 7.74% increase in pig sales revenue in January, totaling 14.35 million RMB [34] - Pengding Holdings reported a 0.07% decrease in consolidated revenue in January, totaling 2.701 billion RMB [35] Group 12 - Hongri Pharmaceutical has received approval for clinical trials of its injectable drug for acute pancreatitis [36][37] - Xinhua Medical has decided to terminate the acquisition of a 36.19% stake in Wuhan Zhongzhi Biotechnology [38] - Tianyu Bio reported an 11.23% decrease in pig sales revenue in January, totaling 54.29 million RMB [39]

天邦食品（002124）(002124.SZ)披露2026年1月份商品猪销售情况，公司2026年1月份销售商品猪68.20 万头(其中仔猪销售29.02万头)，销售收入6.74亿元，销售均价13.60元/公斤(商品肥猪均价为12.50元/公 斤)，环比变动分别为2.97%、10.01%、14.54%;同比变动分别为55.99%、9.93%、-17.83%。 ...

智通财经APP讯，天邦食品(002124.SZ)披露2026年1月份商品猪销售情况，公司2026年1月份销售商品猪 68.20万头(其中仔猪销售29.02万头)，销售收入6.74亿元，销售均价13.60元/公斤(商品肥猪均价为12.50 元/公斤)，环比变动分别为2.97%、10.01%、14.54%;同比变动分别为55.99%、9.93%、-17.83%。 ...

格隆汇2月6日丨天邦食品(002124.SZ)公布，公司2026年1月份销售商品猪68.20万头（其中仔猪销售 29.02万头），销售收入6.74亿元，销售均价13.60元/公斤（商品肥猪均价为12.50元/公斤），环比变动 分别为2.97%、10.01%、14.54%；同比变动分别为55.99%、9.93%、-17.83%。 ...

天邦食品公告称，2026年1月销售商品猪68.20万头（含仔猪29.02万头），销售收入67,438.26万元，销售 均价13.60元/公斤（商品肥猪均价12.50元/公斤），环比变动2.97%、10.01%、14.54%，同比变动 55.99%、9.93%、-17.83%。统计仅含控股子公司，参股公司1月销售商品猪173,559头。1月生猪屠宰头 数146,941头。提示商品猪价格波动会影响业绩，提醒投资者注意风险。 ...

一、商品猪销售情况 证券代码：002124 证券简称：天邦食品 公告编号：2026-005 天邦食品股份有限公司 2026 年 1 月份商品猪销售情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没 有虚假记载、误导性陈述或者重大遗漏。 公司 2026 年 1 月份销售商品猪 68.20 万头（其中仔猪销售 29.02 万头），销售收 入 67,438.26 万元，销售均价 13.60 元/公斤（商品肥猪均价为 12.50 元/公斤），环比变 动分别为 2.97%、10.01%、14.54%；同比变动分别为 55.99%、9.93%、-17.83%。 上述数据统计口径仅包括公司控股子公司，未包括公司参股公司。参股公司 2026 年 1 月份销售各类商品猪合计 173,559 头。 | 年份 | 月份 | 销售数量（万头） | | 销售收入（万元） | | 商品肥猪均价 （元/公斤） | | --- | --- | --- | --- | --- | --- | --- | | | | 当期 | 累计 | 当期 | 累计 | 当期 | | 2026 | 1 | 68.20 | 68.20 | ...

Core Viewpoint - Tianbang Food has set a target to reduce its full cost of fattening pigs to 13.31 yuan/kg in 2025, achieving a decrease of 1.89 yuan/kg year-on-year, while facing a projected net loss of 1.11 billion to 1.31 billion yuan for the same year [2][3] Group 1: Cost Reduction and Sales Performance - The full cost of fattening pigs in December 2025 was reported at 12.92 yuan/kg, and after excluding empty pen costs, it was 12.6 yuan/kg, meeting the cost reduction target set at the beginning of 2025 [2] - The company expects to sell 6.6635 million pigs in 2025, including 2.3936 million piglets, marking an 11.21% increase in sales volume year-on-year (8.7% increase excluding piglets) [2] - The average selling price of commodity pigs in 2025 is projected to be 14.65 yuan/kg, a decrease of 17.85% compared to the average price of 17.84 yuan/kg in 2024 [2] Group 2: Financial Challenges and Impairment Provisions - The company anticipates total interest expenses of approximately 350 million yuan and costs related to unutilized or vacant pig farms of about 325 million yuan, which together will reduce the total profit by approximately 675 million yuan, translating to an average cost of 101 yuan per pig sold in 2025 [2] - Tianbang Food plans to recognize asset impairment provisions for assets showing signs of impairment, expecting to reduce total profit by 761 million to 938 million yuan for the year [3] Group 3: Operational Adjustments and Cash Flow - The company is currently in a pre-restructuring phase, which is a procedure before formal court restructuring, and the outcome of this restructuring remains uncertain [3] - Despite the challenges, the company is actively working on operational optimization and improving cash flow, with an expected net operating cash flow of 850 million to 950 million yuan for the year, which includes repayments of 248 million yuan to farmers [3]

（企业公告） 2月3日，天邦食品发布投资者关系活动记录表。当中披露，关于公司最新的成本情况及未来的成本下降渠道，天邦食 品回复称，公司2025年全年育肥完全成本降至13.31元/公斤，同比下降1.89元/公斤；其中12月份育肥完全成本为12.92 元/公斤，剔除空栏费用后12月为12.6元/公斤，基本实现年初既定的降本目标。这一成果主要得益于报告期内，公司育 肥成活率、出栏均重、PSY 等各项关键养殖指标继续改善，且公司积极响应政策指引，主动优化产能布局，处置/退租 育肥场15个，清退对应育肥产能约9.24万头，一定程度上提高了产能满负荷率。但公司猪场产能利用率仍偏低，导致 单位折旧摊销等固定费用偏高，延缓了降本进程。公司正积极推进预重整相关工作，目标借重整契机，加速空置猪场 的租赁、代养、改造、处置，尽快提高满负荷率，并通过产业链合作、基因升级等措施优化经营水平。上述举措预计 可帮助公司打开成本进一步下降的空间。 ...

证券日报网2月3日讯，天邦食品（002124）在接受调研者提问时表示，2025年公司食品深加工子业务销 量逐步提升，全年销量同比增长约55%，已实现盈利。屠宰业务因产能仍在爬坡，尚未实现盈利。公司 在餐饮渠道与同庆楼（605108）、老乡鸡、谷田稻香、霸碗等主要客户建立稳定合作，同时持续深化商 超渠道布局，目前已成功进入盒马、京东、永辉超市（601933）、大润发等全国知名商超，有效打开C 端消费市场。未来，公司将提升体系内养殖产能对屠宰业务的供应规模，提高屠宰产能利用率，并继续 推进深加工产品的创新与市场开拓，致力于将食品板块打造为重要的利润增长点，从而发挥全产业链布 局的行业优势，进一步增强公司整体的盈利能力和经营稳健性。 ...

Core Viewpoint - Tianbang Food (002124) faces challenges in improving the operational quality of its breeding segment due to low utilization of self-owned capacity and tight funding constraints [1] Group 1: Operational Challenges - The low utilization rate of self-owned capacity has resulted in approximately 325 million yuan in costs due to vacant capacity, significantly burdening production operations [1] - The company has implemented measures such as lease termination, asset disposal, and contract farming to activate assets, but these efforts have not fully mitigated the financial impact [1] Group 2: Financial Constraints - The tight funding situation has slowed down the implementation of operational optimization measures, despite improvements in key performance indicators such as feed-to-meat ratio and labor efficiency in smart breeding farms [1] - The company plans to continue advancing pre-restructuring and restructuring efforts in 2026 to fundamentally address funding constraints, enhance asset quality, and improve capital structure [1] Group 3: Future Strategies - The company aims to accelerate asset activation and collaborate with industry investors for resource integration to overcome current challenges [1]